Condition (MeSH)
Dacryocystitis
ClinicalTrials.gov lists 14 trials for Dacryocystitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
14 of the 14 trials are tagged with Dacryocystitis itself; the rest are tagged with a narrower condition beneath it.
When did Dacryocystitis trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2023 | 1 |
| 2020 | 3 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 1 |
| 2012 | 1 |
| 2003 | 1 |
| 2001 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 14 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Dacryocystitis trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 3 |
| Not applicable | 2 |
| Observational | 9 |
How many Dacryocystitis trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 2 |
| Completed | 8 |
| Terminated | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Dacryocystitis trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Data Yakka, Inc. | 1 |
| National Eye Institute (NEI) | 1 |
| Singapore National Eye Centre | 1 |
Which drugs are being tested for Dacryocystitis? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Pregabalin | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Proparacaine Hydrochloride ophthalmic solution, USP 0.5% | 2 |
| Balanced Salt Solution | 2 |
| Hyaluronic acid 1% | 1 |
| Cataract surgery | 1 |
| Mitomycin C 0.02% | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Dacryocystitis? (9)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Role of anaesthesia in endoscopic and external dacryocystorhinostomy: A meta-analysis of 3282 cases. | European journal of ophthalmology | 2022 | Yes |
| Evaluation of ostium size following endoscopic dacryocystorhinostomy as a predictive factor of outcome: A prospective study. | Journal francais d'ophtalmologie | 2021 | Yes |
| Protective role of commensal bacteria in Sjögren Syndrome. | Journal of autoimmunity | 2018 | Yes |
| Inflammatory Response in Dry Eye. | Investigative ophthalmology & visual science | 2018 | Yes |
| Factors influencing endoscopic dacryocystorhinostomy outcome. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2017 | Yes |
Showing 5 of 9 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.